OM Outset Medical Inc

Price (delayed)

$3.72

Market cap

$187.88M

P/E Ratio

N/A

Dividend/share

N/A

EPS

-$3.48

Enterprise value

$252.23M

Outset is a medical technology company pioneering a first-of-its-kind technology to reduce the cost and complexity of dialysis. The Tablo Hemodialysis System, FDA cleared for use from the hospital to ...

Highlights
OM's gross profit has surged by 63% year-on-year and by 9% since the previous quarter
OM's gross margin is up by 43% year-on-year and by 10% since the previous quarter
OM's EPS is down by 3% year-on-year but it is up by 2.5% since the previous quarter
The equity has plunged by 50% YoY and by 19% from the previous quarter
OM's debt is up by 32% from the previous quarter and by 32% YoY

Key stats

What are the main financial stats of OM
Market
Shares outstanding
50.51M
Market cap
$187.88M
Enterprise value
$252.23M
Valuations
Price to earnings (P/E)
N/A
Price to book (P/B)
1.52
Price to sales (P/S)
1.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.93
Earnings
Revenue
$130.38M
EBIT
-$159.6M
EBITDA
-$152.52M
Free cash flow
-$134.81M
Per share
EPS
-$3.48
Free cash flow per share
-$2.72
Book value per share
$2.45
Revenue per share
$2.63
TBVPS
$6.33
Balance sheet
Total assets
$313.8M
Total liabilities
$190.92M
Debt
$136.19M
Equity
$122.89M
Working capital
$235.9M
Liquidity
Debt to equity
1.11
Current ratio
5.26
Quick ratio
4.33
Net debt/EBITDA
-0.42
Margins
EBITDA margin
-117%
Gross margin
22.2%
Net margin
-132.5%
Operating margin
-130.2%
Efficiency
Return on assets
-52.4%
Return on equity
-102.5%
Return on invested capital
-46.5%
Return on capital employed
-61.7%
Return on sales
-122.4%
Dividend
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A

OM stock price

How has the Outset Medical stock price performed over time
Intraday
9.09%
1 week
9.09%
1 month
-0.8%
1 year
-84.16%
YTD
-31.24%
QTD
-31.24%

Financial performance

How have Outset Medical's revenue and profit performed over time
Revenue
$130.38M
Gross profit
$29M
Operating income
-$169.77M
Net income
-$172.8M
Gross margin
22.2%
Net margin
-132.5%
OM's gross profit has surged by 63% year-on-year and by 9% since the previous quarter
OM's gross margin is up by 43% year-on-year and by 10% since the previous quarter
Outset Medical's revenue has increased by 13% YoY
The operating margin has grown by 7% year-on-year

Growth

What is Outset Medical's growth rate over time

Valuation

What is Outset Medical stock price valuation
P/E
N/A
P/B
1.52
P/S
1.41
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
1.93
OM's EPS is down by 3% year-on-year but it is up by 2.5% since the previous quarter
OM's price to book (P/B) is 61% lower than its last 4 quarters average of 3.9
The equity has plunged by 50% YoY and by 19% from the previous quarter
OM's price to sales (P/S) is 74% lower than its last 4 quarters average of 5.5
Outset Medical's revenue has increased by 13% YoY

Efficiency

How efficient is Outset Medical business performance
Outset Medical's ROE has plunged by 86% YoY and by 16% from the previous quarter
Outset Medical's return on assets has decreased by 28% YoY and by 4.8% QoQ
The return on invested capital has increased by 14% year-on-year
OM's return on sales is up by 11% year-on-year

Dividends

What is OM's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A

There are no recent dividends present for OM.

Financial health

How did Outset Medical financials performed over time
The total assets is 64% greater than the total liabilities
OM's quick ratio is down by 29% year-on-year
The current ratio has declined by 27% year-on-year
OM's debt is 11% more than its equity
The debt to equity has surged by 164% year-on-year and by 63% since the previous quarter
The equity has plunged by 50% YoY and by 19% from the previous quarter

All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise specified.